Frovatriptan succinate monohydrate is a selective 5-HT1B/1D receptor agonist belonging to the triptan class, widely prescribed for the acute treatment of migraine headaches, including those associated… Read more
Frovatriptan succinate monohydrate is a selective 5-HT1B/1D receptor agonist belonging to the triptan class, widely prescribed for the acute treatment of migraine headaches, including those associated with menstruation. This category encompasses a comprehensive range of high-quality reference standards designed to support pharmaceutical analysis, including pharmacopeial and non-pharmacopeial impurities, key metabolites such as hydroxy derivatives, and stable isotope-labelled compounds. These materials are essential for laboratories conducting impurity profiling, method validation, and rigorous quality control testing during the development and stability studies of the drug product. By providing access to the (S)-enantiomer and various related substances, this collection enables precise quantitative analysis and the accurate identification of degradants, ensuring compliance with regulatory requirements throughout the product lifecycle.
